Pinealon

Pinealon is a synthetic tripeptide composed of three amino acids: L-glutamic acid, L-aspartic acid, and L-arginine. The amino acid sequence is written as Glu-Asp-Arg, which is why it is also referred to as the “EDR peptide.” It was originally isolated from Cortexin, a neuroprotective drug derived from pig brain tissue, and subsequently synthesized in laboratory form. Pinealon belongs to a class of compounds called peptide bioregulators. These are short-chain peptides developed primarily in Russia that target specific organs or tissues. As the name suggests, Pinealon targets the pineal gland and the central nervous system. What makes Pinealon unusual among peptides is its size. At just three amino acids, it is one of the smallest bioactive peptides studied for brain health. This compact structure allows it to cross the blood–brain barrier efficiently and even penetrate cell nuclei, where it may interact directly with DNA. Pinealon is not FDA-approved. It remains an experimental compound, with most research coming from preclinical studies and limited human trials conducted primarily in Russia and Eastern Europe.

Key Characteristics

• Molecular formula: C₁₅H₂₆N₆O₈
• Molecular weight: 418.407 g/mol
• Sequence: Glu-Asp-Arg
• PubChem CID: 18220191
• Synonyms: EDR peptide, glutamylaspartylarginine, T-33 peptide
• Classification: Peptide bioregulator
• Origin: Isolated from Cortexin; now produced synthetically

How It Works

Pinealon belongs to a class of compounds known as peptide bioregulators, which are designed to normalize gene expression in specific tissues. In Pinealon’s case, that tissue is the central nervous system, with a strong affinity for the pineal gland. Rather than forcing neurotransmitter release or suppressing symptoms, Pinealon supports the brain’s self-regulation mechanisms.

Direct DNA Interaction

Unlike most peptides that bind to cell-surface receptors, Pinealon appears to cross cell membranes and enter the nucleus. Fluorescence-labeled peptide studies conducted in cultured HeLa cells demonstrate translocation across both cellular and nuclear membranes, enabling direct interaction with nucleic acids. Research suggests it can bind to specific DNA sequences

and influence gene expression. This is called epigenetic regulation—it may turn certain genes on or off without changing the genetic code itself. Molecular studies suggest Pinealon binds to the promoter region of the gene for 5-tryptophan hydroxylase, an enzyme critical for serotonin production. By enhancing this gene’s activity, Pinealon may support serotonin synthesis in the brain. The peptide showed lower (more stable) binding energy compared to similar tripeptides, suggesting a specific and consistent interaction with DNA.

Antioxidant and Anti-Apoptotic Effects

Research shows Pinealon increases the activity of protective enzymes, including SOD2 (superoxide dismutase 2) and GPX1 (glutathione peroxidase 1). These enzymes neutralize reactive oxygen species that damage neurons. Pinealon also suppresses caspase-3, an enzyme that executes cell death (apoptosis). By reducing caspase-3 activity, Pinealon may protect neurons from dying under stress conditions such as oxygen deprivation. Studies on Pinealon have suggested a concentration-dependent action: at lower concentrations, it may exert antioxidant potential, while at higher concentrations, it may interact with the cell genome and modulate the cell cycle.

Neurotrophic Support

Studies in brain cortex cell cultures show Pinealon boosts expression of 5-tryptophan hydroxylase, which increases serotonin production. Serotonin has known neuroprotective and geroprotective (anti-aging) properties. Unlike SSRIs, which recycle existing serotonin, Pinealon supports natural serotonin production and avoids forced neurotransmitter manipulation.

MAPK/ERK Pathway Modulation

Pinealon affects cellular signaling cascades involved in cell survival and stress response. In neurons exposed to toxins, Pinealon delayed the activation of ERK1/2, which helps prevent premature cell-death responses. Reactive oxygen species (ROS) act as secondary messengers in the MAPK and ERK signaling pathways, and by potentially reducing ROS levels, Pinealon may attenuate the activation of these pathways, leading to reduced cellular stress and inhibition of apoptosis.

Pineal Gland Effects

The pineal gland produces melatonin, which regulates sleep–wake cycles. Preliminary research suggests Pinealon may help reset pineal gland function in conditions of circadian rhythm disruption by interacting with circadian gene expression rather than acting as a sedative. This mechanism is not fully understood but represents a distinct approach compared to exogenous melatonin supplementation.

Irisin Modulation

Research suggests Pinealon may also act on muscle cells, modulating the levels of irisin. Irisin is considered central to muscle cell protection and is mainly secreted during physical exertion. It may promote the burning of excessive fat stores and is hypothesized to induce elongation of telomeres (DNA caps). By potentially increasing irisin levels, Pinealon may exert protection of DNA telomeres and counteract cellular aging to some degree.

Benefits

Research suggests the following potential benefits, primarily from cell culture studies, animal models, and limited human observations:

Neuroprotection

• Protects neurons from oxidative stress and oxygen deprivation
• Reduces reactive oxygen species accumulation in brain tissue
• Decreases neuronal cell death under stress conditions
• May preserve dendritic spine structure important for brain function
• Supports anabolic activity in neural tissue

Cognitive Support

• Improved memory performance in animal models
• Better learning retention in studies with diabetic rats
• Potential benefits for age-related cognitive decline
• Improved short-term and long-term memory in human observations
• Faster information processing and fewer cognitive errors under load
• Improved attention and mental work capacity

Sleep and Circadian Rhythm

• Supports endogenous melatonin production via pineal gland signaling
• Modulates serotonin synthesis (a melatonin precursor)
• Interacts with circadian gene expression rather than acting as a sedative
• Improved sleep depth reported in human trials using oral administration
• May benefit shift workers or those with jet lag

Mood Support

• Supports the serotonin synthesis pathway
• Provides a potential alternative mechanism to SSRIs
• May have anxiolytic (anti-anxiety) properties
• Improved emotional stability reported in clinical observations
• Better emotional regulation following brain stress or trauma

Cellular Protection

• Anti-apoptotic effects extend beyond neurons
• May protect cardiac cells after heart attack (animal data)
• Supports skin cell proliferation and regeneration
• General anti-aging effects at the cellular level
• Potential telomere protection via irisin modulation

Hormonal Regulation

• Supports endocrine system function through the pineal gland
• May influence melatonin regulation
• Part of the broader bioregulator approach to hormone balance

Physical Performance and Recovery (Indirect)

• Better neuromuscular coordination
• Improved recovery signaling
• Enhanced adaptation to training stress
• Reduced illness incidence when combined with other bioregulators
• Enhanced antioxidant defense

These indirect benefits are likely mediated through irisin signaling, mitochondrial resilience, and central nervous system efficiency rather than muscle hypertrophy.

What the Science Shows

Research on Pinealon comes primarily from Russian laboratories and includes both preclinical studies and limited human data.

Neuroprotection Studies

Research in prenatal rat models showed Pinealon protected against the damaging effects of elevated homocysteine (hyperhomocysteinemia). Rats whose mothers received Pinealon had significantly reduced reactive oxygen species in their brains and fewer necrotic cells. These rats showed better cognitive function and motor coordination than control groups (Arutjunyan et al., 2012). Confirmation that Pinealon protects against reactive oxygen species and reduces necrotic cell death was accompanied by evidence that the peptide modifies the cell cycle as part of its protective mechanism, activating proliferative pathways that offset some of the damaging effects of oxidative stress. A study on Alzheimer’s disease models found Pinealon prevented dendritic spine elimination and neuroplasticity impairments. Treated neurons showed a 71% increase in functional mushroom-shaped spines, the type most important for learning and memory (Khavinson et al., 2021). This was among the first indications of Pinealon’s relevance to neurodegenerative disease mechanisms.

Gene Expression Research

Molecular studies demonstrated that Pinealon binds to specific DNA sequences in brain cortex cells. This binding increased expression of genes related to serotonin production. The peptide showed lower (more stable) binding energy compared to similar tripeptides, suggesting a specific and consistent interaction with DNA (Ilina et al., 2022). Testing in HeLa cell cultures confirmed that Pinealon directly penetrates both the cell membrane and the nuclear membrane to interact with DNA.

Oxidative Stress Protection

Cell culture studies with neurons exposed to homocysteine toxicity showed Pinealon delayed harmful ERK1/2 activation and reduced cell death. The peptide’s antioxidant effects appear concentration-dependent, with lower doses reducing oxidative damage and higher doses affecting the cell cycle (Khavinson et al., 2011). Research further showed that Pinealon increased cell viability by suppressing free radical levels and activating proliferative processes.

Aging and Longevity Research

Research from Russian laboratories indicates that Pinealon and a similar peptide, Vesugen, demonstrate anabolic potential in the brain and can slow the rate of aging when calculated using biological age indicators. Both peptides exhibited improvement in the functioning of the central nervous system and other vital organs compared to control models (Trofimova et al., 2015). Studies on fibroblast-derived induced neurons showed that short peptides, including Pinealon, protected these cells from age-related changes (Kraskovskaya et al., 2024).

Skin Cell Research

A study by Voicekhovskaya et al. (2012) examined the effect of bioregulatory tripeptides, including Pinealon, on cultures of skin cells from young and old rats. Results showed the peptide supported skin cell proliferation and regeneration, suggesting broader cellular protective properties beyond neurons.

Clinical Observations

Limited human trials have examined Pinealon in older patients with cerebral dysfunction. Oral administration (0.2 mg twice daily) showed effectiveness in correcting brain function issues in elderly populations, with reported improvements in sleep depth, emotional stability, reduced headache frequency, and improved cognitive state. In patients recovering from cranial injury or occupational neurological stress, Pinealon improved memory recall, speech function, attention, and mental work capacity. However, these studies lack the rigorous methodology of Western clinical trials.

Important Context

Most Pinealon research comes from preclinical models or studies with limited controls. The compound shows consistent neuroprotective effects in laboratory settings, but large-scale human trials demonstrating efficacy and safety are not available. Consider this an experimental peptide with promising preliminary data rather than a proven therapeutic agent.

Dosing Protocol

Pinealon dosing is based on practitioner protocols and limited clinical observations rather than robust clinical trial data. Approach with appropriate caution.

Why Doses Are Lower Than Many Peptides

Pinealon is a tripeptide that works through gene expression and epigenetic mechanisms rather than receptor binding. These pathways require smaller amounts to influence cellular behavior. The peptide’s ability to penetrate cell nuclei means low doses can have meaningful effects.

Subcutaneous Administration

This is the most common route for research and clinical use.

Protocol Dose Frequency Duration General neuroprotection 100–300 mcg Once daily 10–20 days Cognitive support 200–300 mcg Once daily 10–20 days Intensive protocol 300 mcg Once daily 20 days

Standard approach: Run cycles of 10 to 20 days, then take 2 to 3 months off before repeating. Some protocols suggest repeating cycles every few months as needed.

Timing Considerations

• Morning administration is generally preferred to align with circadian rhythms.
• Avoid late-day dosing, as it may affect sleep in some individuals.
• Consistent timing helps establish effects.

Oral Administration

Some practitioners use oral Pinealon, though bioavailability data is limited. Russian research on oral administration showed effectiveness for cerebral dysfunction in elderly patients at 0.2 mg twice daily. If using oral form, doses may need to be higher than subcutaneous.

Combination Protocols

Pinealon is sometimes combined with other neuropeptides for synergistic effects:

• Semax or Selank for broader cognitive support
• Cortexin (the parent compound) for comprehensive neuroprotection
• Other bioregulator peptides targeting different organ systems

Important Dosing Notes

• Start at the lower end of dosing ranges.
• Effects are subtle and build over the cycle.
• This is not a stimulant and will not produce immediate noticeable effects.
• Benefits may continue after completing a cycle due to epigenetic mechanisms.

Draw Volumes – 20 mg Vial (2 mL Reconstitution = 10 mg/mL) Dose Volume Units on Insulin Syringe 100 mcg 0.01 mL 1 unit 150 mcg 0.015 mL 1.5 units 200 mcg 0.02 mL 2 units 250 mcg 0.025 mL 2.5 units 300 mcg 0.03 mL 3 units

At 200 mcg daily, one 20 mg vial provides 100 doses. These are very small volumes. Use a U- 100 insulin syringe for accurate measurement.

Reconstitution Instructions

Step 1: Gather supplies: Pinealon vial, bacteriostatic water, alcohol swabs, and syringes. Step 2: Clean the stoppers on both vials with alcohol swabs. Step 3: Draw 2 mL of bacteriostatic water into a syringe. Step 4: Inject the water slowly down the inside wall of the Pinealon vial. Do not spray directly onto the powder. Step 5: Let the powder dissolve naturally. Gently swirl if needed. Do not shake. Step 6: Once fully dissolved, the solution is ready for use. Step 7: Label the vial with the date, concentration (10 mg/mL), and contents.

Concentration Math

With 2 mL reconstitution:

• 20 mg ÷ 2 mL = 10 mg/mL = 10,000 mcg/mL
• Each 0.01 mL (1 unit) = 100 mcg

Side Effects and Cautions

Pinealon appears to be well tolerated based on available research, but data is limited.

Reported Side Effects

• Headache (mild, transient)
• Vivid dreams
• Mild insomnia if taken too late in the day
• Mild anxiety in some individuals
• Transient fatigue
• Dizziness (rare)
• Injection site reactions (redness, itching, minor swelling)
• Gastrointestinal discomfort (rare)

Most Common Issue

Taking Pinealon too late in the day may interfere with sleep onset due to its effects on the pineal gland and circadian regulation. Morning administration avoids this problem.

Severity

Most reported side effects are mild and temporary. Serious adverse events have not been documented in available literature, but long-term safety data is lacking. Pinealon exhibits minimal side effects and excellent subcutaneous bioavailability in preclinical models.

Contraindications and Precautions

Avoid

• Known hypersensitivity to Pinealon or its components
• Pregnancy (safety not established)
• Breastfeeding (safety not established)

Use with Caution

• Epilepsy or seizure disorders (central nervous system–active agents may lower the

seizure threshold in rare cases)

• Currently taking MAO inhibitors or other psychiatric medications
• Existing psychiatric conditions without physician guidance
• Under age 18

Special Considerations

Because Pinealon influences gene expression and neurotransmitter synthesis, it may interact with medications affecting similar pathways. Discuss with a physician if you take antidepressants, anti-anxiety medications, or other psychiatric drugs.

Comparison with Similar Peptides

Pinealon vs. Semax

Semax works primarily through modulating neurotransmitters and neurotrophic factors such as BDNF. Its effects are more immediately noticeable for cognitive enhancement. Pinealon works through deeper cellular repair and gene expression mechanisms. Effects are subtler but may be more fundamental to long-term brain health. Some practitioners combine both for synergistic benefits.

Pinealon vs. Selank

Selank has more pronounced anti-anxiety effects through GABA system modulation. Pinealon’s mood effects come through serotonin pathway support. Selank is better suited for acute anxiety, while Pinealon may provide broader neuroprotective benefits.

Pinealon vs. DSIP

DSIP directly promotes sleep through specific peptide receptors. Pinealon may improve sleep quality through circadian rhythm support and pineal gland regulation. DSIP is more specifically a sleep compound, while Pinealon offers broader cognitive and neuroprotective effects.

Pinealon vs. Epithalon

Both are Russian bioregulator peptides used in cycles. Epithalon targets telomerase for longevity. Pinealon targets the nervous system for neuroprotection. They have different mechanisms and different targets but are sometimes combined in anti-aging protocols.

Feature Pinealon Semax Selank Epithalon Primary target Pineal gland / Neurotrophic GABA system Telomerase CNS factors Mechanism Gene expression BDNF GABA Telomere modulation modulation elongation Onset 1–2 weeks Rapid Rapid Gradual Best for Neuroprotection, Cognitive boost Anxiety relief Longevity sleep Cycling 10–20 days on 10–20 days on 14–21 days on 10–20 days on

Pinealon vs. Typical Nootropics

Pinealon Typical Nootropics Works at the gene expression level Symptom-driven Restores circadian signaling Stimulates or sedates Neuroprotective Often neuro-exhaustive Long-term normalization Short-term effect No stimulant crash Tolerance common

Success Tips

Pinealon works through subtle epigenetic mechanisms. Approach it with realistic expectations.

Set Appropriate Expectations

This is not a stimulant. You will not feel an immediate boost. Effects build over the course of a cycle and may continue after you stop. Many people notice improvements in mental clarity, focus, and sleep quality after one to two weeks, with maximal benefit after approximately three months.

Optimize Timing

Take Pinealon in the morning. This aligns with natural circadian rhythms and avoids potential sleep interference. Consistent timing helps establish effects.

Support Brain Health Foundations

Pinealon enhances a healthy brain; it does not replace foundational practices:

• Quality sleep (7 to 9 hours)
• Regular physical exercise
• Nutrient-dense diet
• Stress management
• Social connection
• Mental stimulation

Consider Cycling

Standard protocols use 10- to 20-day cycles followed by extended breaks. This approach prevents potential adaptation and allows the epigenetic effects to consolidate.

Track Subjective Markers

Since effects are subtle, keep notes on:

• Sleep quality and ease of waking
• Mental clarity and focus
• Mood stability
• Memory and recall
• Energy levels

Storage and Handling

Before Reconstitution

• Store lyophilized (freeze-dried) powder at room temperature (below 25°C / 77°F).
• Keep in a dry location away from light.
• Do not freeze.

After Reconstitution

• Refrigerate at 2–8°C (35–46°F).
• Protect from light.
• Use within 28 to 30 days.
• Do not freeze the reconstituted solution.
• Check for cloudiness or particles before each use; discard if present.

Travel

• Keep refrigerated when possible.
• A cooler with ice packs works for short trips.
• Do not expose to excessive heat.
• Minimize freeze–thaw cycles.

Legal Status

United States

• Not FDA-approved for any medical indication.
• Not a controlled substance.
• Available as a research peptide.
• Use is considered experimental.

International

• Developed and used clinically in Russia and some Eastern European countries.
• Part of Russian bioregulator peptide protocols.
• Regulatory status varies by country.

Important Context

Pinealon is sold as a research chemical. Human use is at your own risk. No medical claims can be made about its efficacy or safety. This is an experimental compound.

Frequently Asked Questions

How quickly will I feel effects from Pinealon? Do not expect immediate effects. Pinealon works through gene expression and cellular repair mechanisms that take time. Most people notice subtle improvements in clarity, focus, or sleep quality after one to two weeks of consistent use. Is Pinealon the same as Cortexin? No. Pinealon was isolated from Cortexin but is a specific tripeptide. Cortexin is a mixture of many polypeptides from brain tissue. Pinealon is the pure, synthetic form of one specific component.

Can I take Pinealon long-term?

Standard protocols use cycled dosing: 10 to 20 days on, 2 to 3 months off. This approach may prevent adaptation and aligns with how bioregulator peptides are typically used. Long-term continuous-use data is not available.

Does Pinealon actually help with Alzheimer’s disease? Preclinical research shows neuroprotective effects relevant to Alzheimer’s disease mechanisms, including preservation of dendritic spines and neuroplasticity. However, no clinical trials prove efficacy in human Alzheimer’s patients. It remains a research compound, not a treatment. Should I take Pinealon in the morning or evening? Morning is preferred. Taking it too late may interfere with sleep in some individuals due to its effects on the pineal gland and circadian regulation. Can I combine Pinealon with other nootropics? Some practitioners combine Pinealon with Semax, Selank, or other neuropeptides. These combinations are experimental. Start compounds individually to assess your response before combining.

Is Pinealon safe?

Available research suggests it is well tolerated, with mild, transient side effects. However, long- term safety studies in humans are lacking. This is an experimental peptide. Use involves inherent uncertainty. What is the best route of administration? Subcutaneous injection is the most common route for research use. Oral administration has been used in Russian clinical settings with reported effectiveness, though bioavailability may be lower than subcutaneous injection. How does Pinealon differ from melatonin supplements? Pinealon does not directly supply melatonin. Instead, it supports the pineal gland’s own signaling and circadian gene expression, which may lead to more restorative sleep over time. Melatonin supplements provide exogenous melatonin that acts as a sedative.

References

1. Arutjunyan A, Kozina L, Stvolinskiy S, Bulygina Y, Mashkina A, Khavinson V. Pinealon protects the rat offspring from prenatal hyperhomocysteinemia. International Journal of Clinical and Experimental Medicine. 2012;5(2):179–185. 2. Khavinson V, et al. EDR peptide: possible mechanism of gene expression and protein synthesis regulation involved in the pathogenesis of Alzheimer’s disease. International Journal of Molecular Sciences. 2021. 3. Khavinson V, et al. Pinealon increases cell viability by suppression of free radical levels and activating proliferative processes. Rejuvenation Research. 2011;14(5):535–541. 4. Ilina A, et al. Neuroepigenetic mechanisms of action of ultrashort peptides in Alzheimer’s disease. International Journal of Molecular Sciences. 2022;23(8):4259. 5. Mendzheritskiĭ AM, et al. Regulation of content of cytokines in blood serum and of caspase-3 activity in brains of old rats in model of sharp hypoxic hypoxia with Cortexin and Pinealon. Advances in Gerontology. 2014. 6. Voicekhovskaya MA, et al. Effect of bioregulatory tripeptides on the culture of skin cells from young and old rats. Bulletin of Experimental Biology and Medicine. 2012. 7. Kraskovskaya N, et al. Short peptides protect fibroblast-derived induced neurons from age- related changes. International Journal of Molecular Sciences. 2024. 8. Trofimova SV, et al. Short peptides and aging. Advances in Gerontology. 2015;28(3):432– 439. 9. Anisimov VN, et al. Effects of short peptides on aging and age-related diseases. Biogerontology. 2010;11(2):139–149. 10. Linkova NS, et al. Peptide regulation of functions of stem cells. Neurochemical Journal. 2017;11(2):120–126. 11. Khavinson VK, Kuznik BI, Tarnovskaya SI, Lin’kova NS. Short peptides and telomere length regulator hormone irisin. Bulletin of Experimental Biology and Medicine. 2016;160(3):347–349. 12. Peptide Sciences. Pinealon: Bioregulator peptide for neuroprotection, cognitive longevity, and epigenetic function. 2024. 13. Wikipedia. Pinealon. December 2024.